Talk:Prefoldin: Difference between revisions

Browse history interactively

← Previous edit Next edit →

Content deleted Content added

VisualWikitext

Inline

Revision as of 18:11, 12 April 2024

Molecular Biology: MCB

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
???	This article has not yet received a rating on the importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance).

Lab research/in vitro review

A novice user is attempting to apply this article as having significance for nanomedicine. The topic is 4 years out of date, and is not established beyond in vitro lab research. It does not have WP:WEIGHT in the nanomedicine field, does not meet WP:MEDASSESS (lowest level of evidence), and is premature to use as a topic or source for nanomedicine. Wait for a WP:BMI-WP:MEDRS review. Zefr (talk) 23:35, 11 April 2024 (UTC)[reply]

For the record, this is the content removed by User Zefr:

As of 2024, the potential prospects of prefoldin in nanomedicine are being explored.^[1]

It is *not* the conclusion of any “Lab research/in vitro” experiments. It’s just stating the fact that “experiments are being conducted / efforts are being made” to explore the potential prospects. I don’t think your personal opinion about WP:MEDRS, WP:WEIGHT and WP:MEDASSESS are valid at all.

BTW, in the source it reads “future … whether they become tumor markers or the application of nanotechnology to treat diseases will be of great significance…” Thanks and regards, --Dustfreeworld (talk) 01:46, 12 April 2024 (UTC)[reply]

References

^ Mo SJ, Zhao HC, Tian YZ, Zhao HL (2020). "The Role of Prefoldin and Its Subunits in Tumors and Their Application Prospects in Nanomedicine". Cancer Manag Res (review). 12: 8847–8856. doi:10.2147/CMAR.S270237. PMC 7520118. PMID 33061580.{{cite journal}}: CS1 maint: unflagged free DOI (link)

A search of PubMed for "prefoldin nanomedicine review" yields only the one 2020 publication in question, i.e., prefoldin is not a topic of active interest in nanomedicine. Further, the journal is not Medline-indexed, indicating it is an unestablished publication of questionable quality for the encyclopedia. There is no good reason to include a statement from an unreliable source about some future unconfirmed value of using prefoldin in nanomedicine, WP:CRYSTAL. Zefr (talk) 14:19, 12 April 2024 (UTC)[reply]

[Mo2020-1] Mo SJ, Zhao HC, Tian YZ, Zhao HL (2020). "The Role of Prefoldin and Its Subunits in Tumors and Their Application Prospects in Nanomedicine". Cancer Manag Res (review). 12: 8847–8856. doi:10.2147/CMAR.S270237. PMC 7520118. PMID 33061580.{{cite journal}}: CS1 maint: unflagged free DOI (link)

[1]

@@ Line 5: / Line 5: @@
 == Lab research/in vitro review ==
+A novice user is [https://en.wikipedia.org/w/index.php?title=Prefoldin&diff=prev&oldid=1218481176 attempting] to apply [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520118/ this article] as having significance for [[nanomedicine]]. The topic is 4 years out of date, and is not established beyond in vitro lab research. It does not have [[WP:WEIGHT]] in the nanomedicine field, does not meet [[WP:MEDASSESS]] (lowest level of evidence), and is premature to use as a topic or source for nanomedicine. Wait for a [[WP:BMI]]-[[WP:MEDRS]] review. [[User:Zefr|Zefr]] ([[User talk:Zefr|talk]]) 23:35, 11 April 2024 (UTC)
-{{Inappropriate comment
-|action=tag
-|reason= [[WP:TALK]] ("Article talk pages should not be used by editors as platforms for their personal views"; "Comments that are plainly irrelevant are subject to archiving or removal.") and WP:NOTFORUM
-|comment=A novice user}} is [https://en.wikipedia.org/w/index.php?title=Prefoldin&diff=prev&oldid=1218481176 attempting] to apply [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520118/ this article] as having significance for [[nanomedicine]]. The topic is 4 years out of date, and is not established beyond in vitro lab research. It does not have [[WP:WEIGHT]] in the nanomedicine field, does not meet [[WP:MEDASSESS]] (lowest level of evidence), and is premature to use as a topic or source for nanomedicine. Wait for a [[WP:BMI]]-[[WP:MEDRS]] review. [[User:Zefr|Zefr]] ([[User talk:Zefr|talk]]) 23:35, 11 April 2024 (UTC)
-:I’m a user with almost 5000 edits and have registered for over 15 months. I don’t know what’s your definition of “novice user”. I hope you are not trying to downgrade other Wikipedian with those untrue claims. You may want to review [[WP:Seniority|this]] too.
 :For the record, this is the content removed by User {{u|Zefr}}:
 :<blockquote><b>As of 2024, the potential prospects of prefoldin in [[nanomedicine]] are being explored.</b><ref name="Mo2020">{{cite journal |vauthors=Mo SJ, Zhao HC, Tian YZ, Zhao HL |title=The Role of Prefoldin and Its Subunits in Tumors and Their Application Prospects in Nanomedicine |journal=Cancer Manag Res |volume=12 |issue= |pages=8847–8856 |date=2020 |pmid=33061580 |pmc=7520118 |doi=10.2147/CMAR.S270237 |type=review}}</ref>
 :</blockquote>
-:It is *not* the conclusion of any “Lab research/in vitro” experiments. It’s just stating the fact that “experiments are being conducted / efforts are being made” to explore the potential prospects. I don’t think your personal opinion about [[WP:MEDRS]], [[WP:WEIGHT]] and [[WP:MEDASSESS]] are valid at all. Citing many WP:UPPERCASE won’t make one right.
+:It is *not* the conclusion of any “Lab research/in vitro” experiments. It’s just stating the fact that “experiments are being conducted / efforts are being made” to explore the potential prospects. I don’t think your personal opinion about [[WP:MEDRS]], [[WP:WEIGHT]] and [[WP:MEDASSESS]] are valid at all.
+:BTW, in the source it reads “future … whether they become tumor markers or the application of nanotechnology to treat diseases will be of great significance…” Thanks and regards, --[[User:Dustfreeworld|<span style="color: navy">'''Dustfreeworld'''</span>]] ([[User talk:Dustfreeworld|talk]]) 01:46, 12 April 2024 (UTC)
-:As I said on your talk, I don't think you are right. Even if you are, please review [[WP:BRIE]]. Please comment on content *instead of* editors. I hope the untrue claims (disruptive, etc.) in edit summaries and talk pages that lasting for weeks (and without any striking / appologies) can stop.
+{{reflist-talk}}
-:BTW, in the source it reads “future … whether they become tumor markers or the application of nanotechnology to treat diseases will be of great significance…” Again, I urge you to be more open-minded to new knowledge, and don’t revert base on reasons such as Idontlikeit or Idontknowit ... Thanks and regards, --[[User:Dustfreeworld|<span style="color: navy">'''Dustfreeworld'''</span>]] ([[User talk:Dustfreeworld|talk]]) 01:46, 12 April 2024 (UTC)
-:{{reflist-talk}}
 [https://pubmed.ncbi.nlm.nih.gov/ A search of PubMed] for "prefoldin nanomedicine review" yields only the one 2020 publication in question, i.e., prefoldin is not a topic of active interest in nanomedicine. [https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cancer+Manag+Res%22%5BTitle+Abbreviation%5D Further, the journal] is not Medline-indexed, indicating it is an unestablished publication of questionable quality for the encyclopedia. There is no good reason to include a statement from an unreliable source about some future unconfirmed value of using prefoldin in nanomedicine, [[WP:CRYSTAL]]. [[User:Zefr|Zefr]] ([[User talk:Zefr|talk]]) 14:19, 12 April 2024 (UTC)